Michael Davidson, M. (2024). OBICETRAPIB TARGETS ALL ATHEROGENIC LIPOPROTEINS BEYOND LDL-C. Elsevier.
Chicago Style (17th ed.) CitationMichael Davidson, MD. OBICETRAPIB TARGETS ALL ATHEROGENIC LIPOPROTEINS BEYOND LDL-C. Elsevier, 2024.
MLA (9th ed.) CitationMichael Davidson, MD. OBICETRAPIB TARGETS ALL ATHEROGENIC LIPOPROTEINS BEYOND LDL-C. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.